Patent ID: 11872225
Assignee: AGIOS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. The method according to claim 1, wherein R2 is selected from hydrogen, hydroxyl, halogen, —C1-C6 alkyl, —C2-C6 alkenyl, —C2-C6 alkoxyl, phenyl, naphthalenyl, C3-6 cycloalkyl, 5-membered heteroaryl, 6-membered heteroaryl, 8-membered bicyclic heteroaryl, and 9-membered bicyclic heteroaryl, wherein each alkyl, alkenyl, phenyl, and heteroaryl is substituted with 0-3 occurrences of Re.